CASP12 | Caspase 12 (gene/pseudogene) | Enzymes
| | | | | Tissue enhanced |
CCBE1 | Collagen and calcium binding EGF domains 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCDC8 | Coiled-coil domain containing 8 | Disease related genes
| | | | | Tissue enhanced |
CCL26 | Chemokine (C-C motif) ligand 26 | Predicted secreted proteins
| | | | | Tissue enhanced |
CDH11 | Cadherin 11, type 2, OB-cadherin (osteoblast) | Cancer-related genes Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDH23 | Cadherin-related 23 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDK15 | Cyclin-dependent kinase 15 | Enzymes
| | | | | Tissue enhanced |
CDON | Cell adhesion associated, oncogene regulated | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLDN11 | Claudin 11 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLSTN2 | Calsyntenin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CPZ | Carboxypeptidase Z | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
CSDC2 | Cold shock domain containing C2, RNA binding | | | | | | Tissue enhanced |
CTB-50L17.14 | Uncharacterized protein | | | | | | Tissue enhanced |
DIO3 | Deiodinase, iodothyronine, type III | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
DIRAS3 | DIRAS family, GTP-binding RAS-like 3 | | | | | | Tissue enhanced |
DPF3 | D4, zinc and double PHD fingers, family 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
EMILIN3 | Elastin microfibril interfacer 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
EML5 | Echinoderm microtubule associated protein like 5 | | | | | | Tissue enhanced |
ENPP6 | Ectonucleotide pyrophosphatase/phosphodiesterase 6 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
EPHA6 | EPH receptor A6 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FGF10 | Fibroblast growth factor 10 | Disease related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FRMPD3 | FERM and PDZ domain containing 3 | Cytoskeleton related proteins
| | | | | Tissue enhanced |
GATA4 | GATA binding protein 4 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
GLI2 | GLI family zinc finger 2 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
GNG4 | Guanine nucleotide binding protein (G protein), gamma 4 | RAS pathway related proteins
| | | | | Tissue enhanced |
GREB1 | Growth regulation by estrogen in breast cancer 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
GSTM5 | Glutathione S-transferase mu 5 | Enzymes
| | | | | Tissue enhanced |
HOXC6 | Homeobox C6 | Transcription factors
| | | | | Tissue enhanced |
HS3ST1 | Heparan sulfate (glucosamine) 3-O-sulfotransferase 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
HS6ST2 | Heparan sulfate 6-O-sulfotransferase 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HTR1E | 5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
IGFBP5 | Insulin-like growth factor binding protein 5 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
INHA | Inhibin, alpha | Predicted secreted proteins
| | | | | Tissue enhanced |
IRS4 | Insulin receptor substrate 4 | Predicted secreted proteins
| | | | | Tissue enhanced |
KCNMB2 | Potassium large conductance calcium-activated channel, subfamily M, beta member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
KCNT2 | Potassium channel, subfamily T, member 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
LAMP5 | Lysosomal-associated membrane protein family, member 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
LINC00908 | Long intergenic non-protein coding RNA 908 | | | | | | Tissue enhanced |
LPAR4 | Lysophosphatidic acid receptor 4 | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
LRRC17 | Leucine rich repeat containing 17 | Predicted secreted proteins
| | | | | Tissue enhanced |
MCC | Mutated in colorectal cancers | | | | | | Tissue enhanced |
MEX3A | Mex-3 RNA binding family member A | | | | | | Tissue enhanced |
MKX | Mohawk homeobox | Transcription factors
| | | | | Tissue enhanced |
NAV3 | Neuron navigator 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
NDP | Norrie disease (pseudoglioma) | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
NDST4 | N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4 | Enzymes
| | | | | Tissue enhanced |
NGF | Nerve growth factor (beta polypeptide) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
NLGN4X | Neuroligin 4, X-linked | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
NR2F2 | Nuclear receptor subfamily 2, group F, member 2 | Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
NRG2 | Neuregulin 2 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |